News

2025 Nov 17

Reviving Exhausted Immune Cells Boosts Tumor Elimination

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body’s immunity. The study led by Weill Cornell Medicine... Read more

2025 Nov 03

Researchers Unveil a Powerful New Gene-Switch Tool

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of any gene in a cell. Such “gene-switch” tools allow scientists to “turn on” or “turn off” a target... Read more

2025 Oct 15

New Mobile Lung Cancer Screening Unit Launches to Improve Access to Care for New Yorkers

A state-of-the-art health screening van launched this month is bringing advanced imaging technology and health education directly to New Yorkers who are at the greatest risk of developing lung cancer. The initiative — a... Read more

2025 Oct 14

Galvanizing Blood Vessel Cells to Expand for Organ Transplantation

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for... Read more

colored dots representing individual cells

2025 Oct 10

Cancer Progression Illuminated by New Multi-Omics Tool

A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in individual cancer cells... Read more

Two scientists conducting research in a lab

2025 Oct 07

Research at Risk: Rooting Out Treatment-Resistant Prostate Cancer

Video of Research at Risk: Rooting out treatment-resistant prostate cancer Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease . Yet doctors and scientists have... Read more

2025 Oct 03

Study Finds Restoring Order to Dividing Cancer Cells May Prevent Metastasis

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest to treat breast cancers, but a new study led by Weill Cornell Medicine suggests a way to stop it from spreading. Researchers have discovered that... Read more

The illustration depicts part of the process where a small guide RNA delivers a protein bearing a special amino acid to the desired region. Exposure to UV light then crosslinks the amino acid to nearby proteins. Credit: Dr. Jiajun Zhu

2025 Oct 02

New Tool Identifies Proteins That Control Gene Activity

The SCOPE system can capture proteins binding to regions of DNA that control gene expression. The illustration depicts part of the process where a small guide RNA delivers a protein bearing a special amino acid to the... Read more

2025 Aug 14

Two Weill Cornell Medicine Scientists Selected for 2025 Pew Awards

Weill Cornell Medicine faculty member Dr. Anna Nam and postdoctoral fellow Dr. Maria Cecilia Lira have been chosen to join the 2025 class of Pew scholars and fellows. Dr. Nam, an assistant professor of pathology and... Read more

2025 Aug 11

What’s Melanoma? A Primer on This Dangerous Skin Cancer

Skin cancer is the most common type of cancer in America. Melanoma skin cancer is the least common type, making up only 1 out of 100 skin cancers, according to the American Cancer Society . If it’s so rare, what’s the big... Read more

2025 Aug 11

Laura Pinheiro, PhD, MPH, Appointed to Co-Lead Community Outreach and Engagement at the Sandra and Edward Meyer Cancer Center

The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork - Presbyterian Hospital has appointed Laura Pinheiro, PhD, MPH to join Erica Phillips, MD in co-leading the Center’s Office of Community... Read more

2025 Jul 31

Not All Low-Grade Prostate Cancers Are Low Risk

A new study reveals that some men who are diagnosed with “Grade Group one” (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell Medicine, University... Read more

2025 Jul 29

Uncovering How a Molecule Responsible for Immune “Brakes” Directs Skin Defenses

Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin. Early... Read more

2025 Jul 17

Study Reveals New Clues in Liver Disease Prevention

The aging liver undergoes dramatic changes in its functional organization and other key attributes, which may underpin its increasing susceptibility to disease, according to a study led by investigators at Weill Cornell... Read more

Participants in the Empire State Cellular Therapy Consortium in February 2025 at Roswell Park Comprehensive Cancer Center, Buffalo, NY.

2025 Jul 10

Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

Experts in newest treatment option for cancer, neurological disorders unite to speed progress, expand access Consortium members will share resources, collaborate on clinical trials Statewide experts look to expand benefits... Read more

2025 Jul 07

New Precision Medicine Approach Identifies a Promising Ovarian Cancer Treatment

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The research reveals a promising... Read more

woman pointing at a computer screen while another woman looks on

2025 Jun 24

Research at Risk: Stopping Metastatic Cancer

Video of Research at Risk: Stopping metastatic cancer Metastasis. It’s the word cancer patients dread most – and the scan with ominous black spots showing the disease has spread. For too many people, metastatic cancer is... Read more

A man in a suit giving a presentation at a podium

2025 Jun 03

Dr. Nikolaos Koundouros Wins 2025 Tri-Institutional Breakout Award

Dr. Nikolaos Koundouros , a postdoctoral associate in the Department of Pharmacology at Weill Cornell Medicine, has been awarded a 2025 Tri-Institutional Breakout Award for Junior Investigators. Weill Cornell Medicine,... Read more

researcher holding a vial of blood over a rack of vials

2025 Jun 02

Switch to Experimental Drug after Liquid Biopsy Detection of Breast Cancer Recurrence Improves Outcomes

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new... Read more

2025 May 29

New Insights into Bladder Cancer Treatment Could Help Improve Immunotherapies

Bacillus Calmette-Guerin (BCG) vaccine. Courtesy of Memorial Sloan Kettering Cancer Center. More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first... Read more